Skip to main content
. 2018 Jan 8;67(1):50–57. doi: 10.1093/cid/ciy012

Table 2.

Rates and Standardized Incidence Ratios of Cancers in Older Persons Living With Human Immunodeficiency Virus Infection (Age ≥50 Years)

Cancers Observed Cases, No. Expected Cases, No. IR per 100000 PY SIR (95% CI)
All cancers 10371 8929 1117.3 1.16 (1.14–1.18)
ADCs
 Kaposi sarcoma 338 3.3 36.4 103.34 (92.62–114.97)
 NHL 1222 401.2 131.7 3.05 (2.88–3.22)
  Diffuse large B cell 674 110.0 72.6 6.12 (5.67–6.61)
  Burkitt 103 7.5 11.1 13.75 (11.23–16.68)
  CNS 74 8.1 8.0 47.39 (37.21–59.49)
  Other/unspecified 371 282.1 39.9 1.32 (1.18–1.46)
 Cervical cancer 87 43.0 36.5 2.02(1.62–2.49)
NADCs
 Anal 524 37.4 56.5 14.00 (12.82–15.25)
 Lung 1725 1012 185.8 1.71 (1.63–1.79)
 Liver 805 276.4 86.7 2.91 (2.71–3.12)
 Hodgkin lymphoma 253 33.3 27.3 7.61 (6.70–8.60)
 Oral cavity/pharynx 461 278.4 49.7 1.66 (1.51–1.81)
 Female breast 329 542.0 137.9 0.61 (.54–.68)
 Prostate 1341 2829 194.5 0.47 (.45–.50)
 Colon (excluding rectum) 360 571.3 38.8 0.63 (.57–.70)
 Other cancers 2926 5731 315.2 1.01 (.97–1.05)

Abbreviations: ADCs, AIDS-defining cancers; CI, confidence intervals; CNS, central nervous system; IR, incidence rate; NADCs, non–AIDS-defining cancers; NHL, non-Hodgkin lymphoma; PY, person-years; SIR, standardized incidence ratio.